Viking Therapeutics, Inc. (VKTX)

NASDAQ: VKTX · Real-Time Price · USD

23.83

+0.23 (0.97%)

At close: Apr 17, 2025, 4:00 PM

23.99

+0.16 (0.67%)

After-hours: Apr 17, 2025, 7:46 PM EDT

Viking Therapeutics Cash Flow Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	2015 - 2019
Period Ending	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	2015 - 2019
Net Income	-109.96	-85.9	-68.87	-54.99	-39.5	Upgrade
Depreciation & Amortization	0.35	0.29	0.29	0.3	0.28	Upgrade
Other Amortization	0.09	0.09	0.06	0.02	0.11	Upgrade
Loss (Gain) From Sale of Investments	-17.38	-8.2	1.22	3.91	3.77	Upgrade
Stock-Based Compensation	29.71	16.75	8.67	6.1	5.82	Upgrade
Other Operating Activities	0.04	0.04	0.04	0.01	0.03	Upgrade
Change in Accounts Payable	2.3	-1.02	7.09	-2.54	1.56	Upgrade
Change in Other Net Operating Assets	7.06	4.57	3.1	-0.38	6.16	Upgrade
Operating Cash Flow	-87.79	-73.38	-48.4	-47.59	-21.78	Upgrade
Investment in Securities	-553.37	-179.09	54.75	37.96	41.57	Upgrade
Investing Cash Flow	-553.37	-179.09	54.75	37.96	41.57	Upgrade
Issuance of Common Stock	654.57	278.5	12.51	7.63	1.27	Upgrade
Repurchase of Common Stock	-42.1	-7.12	-8.33	-0.71	-0.3	Upgrade
Other Financing Activities	-	-	-0.02	-0.05	-0.03	Upgrade
Financing Cash Flow	612.46	271.38	4.16	6.88	0.95	Upgrade
Foreign Exchange Rate Adjustments	-0.15	-0.03	-0.26	-	-	Upgrade
Net Cash Flow	-28.84	18.88	10.26	-2.75	20.74	Upgrade
Levered Free Cash Flow	-55.58	-42.36	-25.22	-32.16	-15.06	Upgrade
Unlevered Free Cash Flow	-55.61	-42.4	-25.24	-32.16	-15.1	Upgrade
Change in Net Working Capital	-8.66	-3.58	-9.76	3.76	-5.47	Upgrade

Updated Feb 26, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q